OBJECTIVES: We sought to identify correlates of reported lifetime diagnoses of TB among injection drug users in the border city of Tijuana, Mexico. METHODS: Injection drug users in Tijuana were recruited into a prospective cohort study during 2006 and 2007. We used weighted multivariate logistic regression to identify correlates of TB diagnoses. RESULTS: Of the 1056 participants, 103 (9.8%) reported a history of TB, among whom 93% received anti-TB medication and 80% were diagnosed in the United States. Treatment was prematurely halted among 8% of patients; deportation from the United States was the cause of half of these treatment interruptions. History of travel to (odds ratio [OR] = 6.44; 95% confidence interval [CI] = 1.53, 27.20) or deportation from (OR = 1.83; 95% CI = 1.07, 3.12) the United States and incarceration (OR = 2.20; 95% CI = 1.06, 4.58) were independently associated with a reported lifetime diagnosis of TB. CONCLUSIONS: Mobility and migration are important factors in identifying and treating TB patients diagnosed in the US-Mexico border region. Strengthening capacity on both sides of the border to identify, monitor, and treat TB is a priority.
OBJECTIVES: We sought to identify correlates of reported lifetime diagnoses of TB among injection drug users in the border city of Tijuana, Mexico. METHODS: Injection drug users in Tijuana were recruited into a prospective cohort study during 2006 and 2007. We used weighted multivariate logistic regression to identify correlates of TB diagnoses. RESULTS: Of the 1056 participants, 103 (9.8%) reported a history of TB, among whom 93% received anti-TB medication and 80% were diagnosed in the United States. Treatment was prematurely halted among 8% of patients; deportation from the United States was the cause of half of these treatment interruptions. History of travel to (odds ratio [OR] = 6.44; 95% confidence interval [CI] = 1.53, 27.20) or deportation from (OR = 1.83; 95% CI = 1.07, 3.12) the United States and incarceration (OR = 2.20; 95% CI = 1.06, 4.58) were independently associated with a reported lifetime diagnosis of TB. CONCLUSIONS: Mobility and migration are important factors in identifying and treating TBpatients diagnosed in the US-Mexico border region. Strengthening capacity on both sides of the border to identify, monitor, and treat TB is a priority.
Authors: Teresa N Quitugua; Barbara J Seaworth; Stephen E Weis; Jeffery P Taylor; J Seb Gillette; Ishmael I Rosas; Kenneth C Jost; D Mitchel Magee; Rebecca A Cox Journal: J Clin Microbiol Date: 2002-08 Impact factor: 5.948
Authors: R S Garfein; R Lozada; L Liu; R Laniado-Laborin; T C Rodwell; R Deiss; J Alvelais; A Catanzaro; P G Chiles; S A Strathdee Journal: Int J Tuberc Lung Dis Date: 2009-05 Impact factor: 2.373
Authors: Argentina E Servin; Fátima A Muñoz; Steffanie A Strathdee; Justine Kozo; María Luisa Zúñiga Journal: J Int Assoc Physicians AIDS Care (Chic) Date: 2012-08-27
Authors: Michele G Velasquez; Rafael Laniado-Laborin; Timothy C Rodwell; Paris Cerecer; Remedios Lozada; Jazmine Cuevas-Mota; Jose Luis Burgos; Richard S Garfein Journal: Rev Panam Salud Publica Date: 2012-07
Authors: R F Armenta; K M Collins; S A Strathdee; M A Bulterys; F Munoz; J Cuevas-Mota; P Chiles; R S Garfein Journal: Int J Tuberc Lung Dis Date: 2017-04-01 Impact factor: 2.373
Authors: Jeffrey D Schulden; Thomas M Painter; Binwei Song; Eduardo Valverde; Mary Ann Borman; Kyle Monroe-Spencer; Greg Bautista; Hassan Saleheen; Andrew C Voetsch; James D Heffelfinger Journal: J Immigr Minor Health Date: 2014-10
Authors: Tyson Volkmann; Sanghyuk S Shin; Richard S Garfein; Thomas L Patterson; Robin A Pollini; Karla D Wagner; Irina Artamanova; Steffanie A Strathdee Journal: J Immigr Minor Health Date: 2012-04